Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of High-dose Cyclophosphamide for Moderate to Severe Refractory Multiple Sclerosis

NCT00296205 is registered in ClinicalTrials.gov with Stony Brook University as lead sponsor.

NCT NCT00296205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00296205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of High-dose Cyclophosphamide for Moderate to Severe Refractory Multiple Sclerosis
Lead sponsor
Stony Brook University
Phase
Phase 2
Overall status
Withdrawn
Start date
October 31, 2003
Completion date
February 28, 2006
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis